Development of a Fetal Sex Assay From Maternal Whole Blood

Completed

Conditions studied: Fetal Sex Determination

In brief

Whole blood from pregnant women will be collected to develop a noninvasive fetal sex test.

Key facts

Study ID

NCT00970047

Run by

Sequenom, Inc.

People needed

500

Starts

2008-06-01

Expected to finish

2010-07-01

Last updated by the study team

2011-02-02

Who can join

Age: 18 and older, up to 64. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Subject is 18-64 years of age
• Subject is female
• Subject is pregnant and between 6 and 16 weeks of gestation
• Subject provides a signed and dated informed consent
• If subject undergoes a routine ultrasound between weeks 16 and 28, she agrees to provide the fetal sex results
• If subject undergoes an invasive procedure, she agrees to provide the fetal sex results

You may not qualify if…

• None

Where it is running

• NCOG Medical Group — San Diego, California, United States
• IGO — San Diego, California, United States
• Scripps Clinic Medial Group — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.